当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2020-03-22 , DOI: 10.1111/apt.15693 Ka Shing Cheung 1, 2 , Lijia Chen 1 , Esther W Chan 3 , Wai Kay Seto 1, 2 , Ian C K Wong 3, 4 , Wai K Leung 1
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2020-03-22 , DOI: 10.1111/apt.15693 Ka Shing Cheung 1, 2 , Lijia Chen 1 , Esther W Chan 3 , Wai Kay Seto 1, 2 , Ian C K Wong 3, 4 , Wai K Leung 1
Affiliation
Although nonsteroidal anti‐inflammatory drugs (NSAIDs) reduce colorectal cancer (CRC) risk, their role in preventing post‐colonoscopy CRC (PCCRC) remains undetermined.
中文翻译：
非甾体类抗炎药而非阿司匹林与结肠镜检查后结直肠癌的风险较低。
尽管非甾体类抗炎药（NSAIDs）降低了结直肠癌（CRC）的风险，但它们在预防结肠镜检查后CRC（PCCRC）中的作用仍未确定。
更新日期：2020-04-22
中文翻译：
非甾体类抗炎药而非阿司匹林与结肠镜检查后结直肠癌的风险较低。
尽管非甾体类抗炎药（NSAIDs）降低了结直肠癌（CRC）的风险，但它们在预防结肠镜检查后CRC（PCCRC）中的作用仍未确定。
京公网安备 11010802027423号